Skip to main content
SpringerLink
Log in

Evaluation of growth hormone bioactivity using the Nb2 cell bioassay in children with growth disorders

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The Nb2 cell bioassay could be a useful tool for evaluating human growth hormone (hGH) bioactivity, but is not specific for hGH since it relies on the ability of the hormone to produce effects by cross-reacting with the lactogenic receptor on Nb2 cells. We studied the biological activity of both endogenous and exogenous hGH in short patients using the Nb2 bioassay after inhibiting the mitogenic effect of the other lactogenic hormone, that is human prolactin (hPRL), by adding a specific antibody against hPRL to each assay. The in vitro study showed a significant (p<0.0001) increase in Nb2 cell proliferation when increasing concentrations of highly purified hGH were added to the cell culture. A complete inhibition of Nb2 cell replication was observed after adding a specific antibody against hGH. The in vivo study showed a significantly (p<0.0001) lower hGH bioactivity (4.90±0.28 ng/ml) evaluated during stimulation tests in 9 children with total idiopathic GH deficiency, mean age 9.25±1.99 years, in comparison with that found in 11 short children with normal growth velocity, mean age 8.22±1.41 years (12.25±1.19 ng/ml). Likewise, serum GH levels measured by immunofluorometric assay IFMA in the same serum samples were significantly (p<0.001) lower in the 9 GH-deficient (1.97±0.37 ng/ml) than in the 11 short children (21.85±2.71 ng/ml). Moreover, we evaluated GH concentrations using both IFMA and the Nb2 cell bioassay in serum samples collected from another 11 idiopathic GH-deficient children, mean age 10.71±1.18 years, before and then, 6 and 24 hours following the 1st injection of r-hGH (0.1 IU/kg sc). Serum GH values measured by both IFMA and Nb2 bioassay significantly (p<0.0001) increased 6 hours after r-hGH administration and decreased to reach basal levels after 24 hours. In conclusion, the Nb2 cell bioassay with minor modifications seems to provide a specific and sensitive assessment of hGH bioactivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Woodhead S., Turner G. Accuracy of growth hormone measurements. Horm. Res. (Suppl.) 36: 17, 1991.

    Article  PubMed  Google Scholar 

  2. Granada M.L., Sanmartí A., Lucas A., Salinas I., Carrascosa A., Foz M., Audi L. Assay-dependent results of immunoassayable spontaneous 24-hour growth hormone secretion in short children. Acta Paediatr. Scand. (Suppl.) 370: 63, 1990.

    Article  CAS  Google Scholar 

  3. Chatelain P., Bouillat B., Cohen R., Sassolas G., Souberbielle J.C., Ruitton A., Joly M.O., Job J.C. Assay of growth hormone levels in human plasma using commercial kits: analysis of some factors influencing the results. Acta Paediatr. Scand. (Suppl.) 370: 56, 1990.

    Article  CAS  Google Scholar 

  4. Celniker A.C., Chen A.B., Wert R.M. Jr, Sherman B.M. Variability in the quantitation of circulating growth hormone using commercial immunoassays. J. Clin. Endocrinol. Metab. 68: 469, 1989.

    Article  CAS  PubMed  Google Scholar 

  5. Baumann G. Growth hormone binding proteins and various forms of growth hormone: implications for measurements. Acta Paediatr. Scand. (Suppl.) 370: 72, 1990.

    Article  CAS  Google Scholar 

  6. Gorden P., Weintraub B.D. Radioreceptor and other functional hormone assays. In: Wilson J.D., Foster D.W. (Eds.), Williams Textbook of Endocrinology, ed 7. Saunders, Philadelphia, 1985, p. 133.

    Google Scholar 

  7. Emoto N., Tsushima T., Shizume K., Tanaka T., Saji M., Ohba Y., Wakai K., Arai M., Ohmura E. Biological activities of human growth hormone and its derivatives by measuring DNA synthesis in Nb2 node rat lymphoma cells. Acta Endocrinol. (Copenh.) 114: 283, 1987.

    CAS  Google Scholar 

  8. Tanaka T., Shiu R.P.C., Gout P.W., Beer C.T., Noble R.L., Friesen H.G. A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum. J. Clin. Endocrinol. Metab. 51: 1058, 1980.

    Article  CAS  PubMed  Google Scholar 

  9. Friesen H.G. Receptor assays for growth hormone. Acta Paediatr. Scand. (Suppl.) 370: 87, 1990.

    Article  CAS  Google Scholar 

  10. Walker A., Croze F., Friesen H.G. A serum-free medium for culturing lactogen dependent and autonomous Nb2 node lymphoma cells. Endocrinology 120: 2389, 1987.

    Article  CAS  PubMed  Google Scholar 

  11. Albertsson-Wikland K., Jansson C., Rosberg A., Novamo A. Time-resolved immunofluorometric assay of human growth hormone. Clin. Chem. 39: 1620, 1993.

    CAS  PubMed  Google Scholar 

  12. Rott A.W., Duckett G.E., Geiszier J.E., Hu C.S., Bercu B.B. Evaluation of the clinical utility of the ultrasensitive immunofluorometric assay for growth hormone (GH) and of the cortisol secretory pattern in prediction of the linear growth response to treatment with G.H. J. Pediatr. Endocrinol. Metab. 13: 3, 1997.

    Google Scholar 

  13. Baumann G. Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins. Endocr. Rev. 12: 424, 1991.

    Article  CAS  PubMed  Google Scholar 

  14. Baumann G. Metabolism of growth hormone (GH) and different molecular forms of GH in biological fluids. Horm. Res. (Suppl.) 36: 5, 1991.

    Article  CAS  PubMed  Google Scholar 

  15. Lesniak M.A., Gorden P. H., Roth J. Reactivity of non-primate growth hormones and prolactins with human growth hormone receptors on cultured human lymphocytes. J. Clin. Endocrinol. Metab. 44: 838, 1977.

    Article  CAS  PubMed  Google Scholar 

  16. Dattani M.T., Hindmarsh P.C., Pringle P.J., Brook C.G.D., Marshall N.J. The measurement of growth hormone bioactivity in patient serum using an eluted stain assay. J. Clin. Endocrinol. Metab. 80: 2675, 1995.

    CAS  PubMed  Google Scholar 

  17. Dattani M.T., Winrow A.P., Tuil’Pakov A., Pringle P.J., Hindmarsh P.C., Brook C.G.D., Marshall N.J. Evaluation of growth hormone (GH) responses to pulsed GH-releasing hormone administration using the MTT-ESTA bioassay. Eur. J. Endocrinol. 135: 87, 1996.

    Article  CAS  PubMed  Google Scholar 

  18. Foster C.M., Borondy M., Padmanabhan V., Schwartz J., Kletter G.B., Hopwood N.J., Beitins I.Z. Bioactivity of human growth hormone in serum: validation of an in vitro bioassay. Endocrinology 132: 2073, 1993.

    CAS  PubMed  Google Scholar 

  19. Mellado M., Rodriguez-Frade J.M., Kremer L., Martinez-Alonso C. Characterization of monoclonal antibodies specific for the human growth hormone 22K and 20 K isoforms. J. Clin. Endocrinol. Metab. 81: 1615, 1996.

    Google Scholar 

  20. Strasburger C.J., Wu Z., Pflaum C.D., Dressendörfer R.A. Immunofunctional assay of human growth hormone (hGH) in serum: a possible consensus for quantitative hGH measurement. J. Clin. Endocrinol. Metab. 81: 2613, 1996.

    CAS  PubMed  Google Scholar 

  21. Cunningham B.C., Bass S., Fuh G., Wells J.A. Zinc mediation of the binding of human growth hormone to the human prolactin receptor. Science 250: 1709, 1990.

    Article  CAS  PubMed  Google Scholar 

  22. Cunningham B.C., Wells J.A. Rational design of receptor-specific variants of human growth hormone. Proc. Natl. Acad. Sci. USA 88: 3407, 1991.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Paediatrics, University of Pavia, Pavia, Italy

    Mauro Bozzola, M. Zecca, F. Locatelli & S. Pagani

  2. Department of Paediatrics, Bolzano, Italy

    G. Radetti

  3. Department of Clinical Chemistry, IRCCS Policlinico San Matteo, Pavia, Italy

    M. Autelli

  4. Department of Paediatrics, University of Verona, Verona, Italy

    L. Tatò

  5. Department of Endocrinology and Diabetology, Lyon, France

    P. Chatelain

Authors
  1. Mauro Bozzola
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Zecca
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Locatelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Radetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Pagani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Autelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. L. Tatò
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P. Chatelain
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bozzola, M., Zecca, M., Locatelli, F. et al. Evaluation of growth hormone bioactivity using the Nb2 cell bioassay in children with growth disorders. J Endocrinol Invest 21, 765–770 (1998). https://doi.org/10.1007/BF03348043

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348043

Key-words

Search

Navigation